LTGO Conversion Disclosure
Sanofi · SEC Form 4 · Filed Aug 12, 2026
Conversion
Reported value range
Not reported
Sanofi 10% owner
LTGO
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
LTGO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Convertible Promissory Note on Common Stock
- Quantity / price
- 177,978 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001193125-26-345826
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO Current | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |